← SynDRA
REVERSINE
SynDRA canonical compound SYN0005765 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | AURKB |
| Mechanism of action | Aurora kinase inhibitor |
All known targets
- ADORA3
- AURKB
- MAP2K1
- AURKA
- INCENP
Mechanisms of action (all sources)
- aurora kinase inhibitor
- ADORA3 INHIBITOR
- MAP2K1 INHIBITOR
Cross-references
Synonyms
- 2-(4-Morpholinoanilino)-6-cyclohexylaminopurine
- UNII-Z499CLJ023
- CHEMBL188343
- CHEBI:70723
- ZFLJHSQHILSNCM-UHFFFAOYSA-N
- Z499CLJ023
- N~6~-Cyclohexyl-N~2~-(4-Morpholin-4-Ylphenyl)-9h-Purine-2,6-Diamine
- IN1127
- 9H-Purine-2,6-diamine,N6-cyclohexyl-N2-[4-(4-morpholinyl)phenyl]-
- C21H27N7O
- N6-cyclohexyl-N2-(4-morpholinophenyl)-7H-purine-2,6-diamine
- N(6)-cyclohexyl-N(2)-[4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine
- 2vgo
- Reversine(HPLC)
- AD5
- AC1L4OI2
- AC1Q4YB4
- MLS006010275
- SCHEMBL1800790
- RefChem:179034
- DTXCID6021113
- N6-cyclohexyl-N2-(4-morpholinophenyl)-9H-purine-2,6-diamine
- MFCD07784513
- Reversine?
- REVERSINE [MI]
- orb1307369
- SCHEMBL1800795
- SCHEMBL29353565
- EX-A268
- GLXC-04582
- HMS3229N05
- HMS3747M21
- BDBM50170831
- HSCI1_000387
- s7588
- Reversine, >=98% (HPLC), solid
- AKOS025404909
Look up REVERSINE in the interactive SynDRA portal →